Onconetix, Inc. Cash and Cash Equivalents
Onconetix, Inc. (ONCO) had Cash and Cash Equivalents of $25.75 million as of 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2023-03-09
- 2022-12-31: Cash and Cash Equivalents, at Carrying Value $25.75M.
- 2022-09-30: Cash and Cash Equivalents, at Carrying Value $29.14M.
- 2022-06-30: Cash and Cash Equivalents, at Carrying Value $22.24M.
- 2022-03-31: Cash and Cash Equivalents, at Carrying Value $18.61M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2022-12-31 | $25.75M 10-K · filed 2023-03-09 |
| 2022-09-30 | $29.14M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $22.24M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $18.61M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $1.93M 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |